Previous Close | 26.68 |
Open | 26.47 |
Bid | 25.87 x 400 |
Ask | 25.95 x 200 |
Day's Range | 25.73 - 26.69 |
52 Week Range | 23.14 - 35.56 |
Volume | |
Avg. Volume | 482,022 |
Market Cap | 1.222B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Key Insights Mirum Pharmaceuticals' Annual General Meeting to take place on 5th of June Total pay for CEO Chris Peetz...
Mirum's (MIRM) lead drug, Livmarli, continues to generate steady sales. The recent label expansion of the drug should drive sales further. However, overdependence on Livmarli for revenues is a concern.